618P - Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group

Autor: Kwakman, J.J., Van Werkhoven, E., Simkens, L.H., van Rooijen, J.M., van de Wouw, A., Ten Tije, A.J., Creemers, G.-J., Hendriks, M.P., Los, M., van Alphen, R., Polee, M.B., Muller, E.W., Van der Velden, A., Van Voorthuizen, T., Koopman, M., Mol, L., Punt, C.J.A.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v233-v234
Databáze: ScienceDirect